Analysts see lower sales for Abbott’s Niaspan – BusinessWeek

Analysts see lower sales for Abbott's Niaspan BusinessWeek On Thursday federal scientists halted a large study of its Niaspan drug, a prescription form of niacin , after preliminary results showed the pill failed to prevent heart attacks or strokes. Niacin is a form of vitamin B that boosts good cholesterol , ... Read more »

Abbott Labs files suit against Impax over Simcor patent challenge; Ranbaxy … – The Pharma Letter

Abbott Labs files suit against Impax over Simcor patent challenge; Ranbaxy ... The Pharma Letter ... has initiated a challenge of patents listed in connection with the cholesterol lowerer Simcor ( niacin /simvastatin) extended-release tablets, 1000/20mg. Read more »